trademark “Wuttisak Clinic”. 3. Analysis of Operating Results Profit & Loss Statements (MB) Consolidated Financial Statements 2017 2016 +/(-) % Revenues from sales and services . . . . % Gross profit from
period of the previous year due to the fluctuation of the Thai Baht. หนา้ 3 จาก 4 Finance Cost The Company’s financial cost in 3rd quarter of 2018 was at Baht 5.58 million increasing at Baht 4.08 million
of last year, Q1/2020’s net profit margin was a few dropped due to the improving budget cost which mention above. Including, increasing of finance cost by short term loan from a financial institution
Plc. would like to inform its financial results for the year 2018 which ended on 31 December 2018. The Company and its subsidiaries reported a net profit of THB 305.93 million or earnings per share of
% Portion of the Companies’ shareholders (272,672) (166,308) 64% (358,157) (621,089) -42% Margin -14% -8% -24% -38% 2 Financial performance in 2019 Revenue from sales and services for the year 2019 is Baht
of receivable under finance lease agreement, gain on forward contracts and insurance claim. Change Consolidated financial statements Financial Performance of the Group 2 Sales and service income for
engaged in distribution of product and equipment, design, assembly and installation, and maintenance service of pure water treatment system; including operate clinical business which Hemodialysis services
, and business related to FinTech. According to the results of operations in the year 2018, the Company had a net loss in the consolidated financial statements in the amount of 277 million baht, incurred
81.48 32.0% 84.30 30.8% Total revenues from HR solutions 200.96 79.0% 213.58 78.0% 2. Financial Solutions 2.1 Enterprise Resource Planning (ERP) 41.12 16.2% 42.09 15.4% 2.2 Accounting & Finance